NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin
National Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
Buyer
NHS England
Value
£1,200,000,000
Published
16 Dec 2024
Closes
26 Feb 2021
Procurement details
Source
Find a Tender
Region
London
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33651520
Immunoglobulins
Lots
Lot 1-9 Lot No: 1-9
Value not provided
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no...
Delivery: United Kingdom
Lot 1 Lot 1 - 5% Intravenous Immunoglobulin (5% IVIg)
£1,600,000,000
This modification notice is to provide notice of the modification of the framework agreement (as defined below) to (i) extend its duration with a limited number of suppliers and (ii) increase the estimated value of the framework agreement across all lots. <br/>The modification is further described in sections VII.2.1 and VII.2.2 below, but in short NHS Engla...
Delivery: United Kingdom
Lot 2 Lot 2: 10% Intravenous Immunoglobulin (10% IVIg)
Value not provided
10% Intravenous Immunoglobulin (10% IVIg)
Delivery: United Kingdom
Lot 3 Lot 3: Subcutaneous Immunoglobulin (SCIg)
Value not provided
Subcutaneous Immunoglobulin (SCIg)
Delivery: United Kingdom
Lot 4 Lot 4: Facilitated Subcutaneous Immunoglobulin (fSCIg)
Value not provided
Facilitated Subcutaneous Immunoglobulin (fSCIg)
Delivery: United Kingdom
Lot 6 Lot 6: 10% Intravenous Immunoglobulin (10% IVIg)
Value not provided
10% Intravenous Immunoglobulin (10% IVIg)
Delivery: United Kingdom
Lot 5 Lot 5: 5% Intravenous Immunoglobulin (5% IVIg)
Value not provided
5: 5% Intravenous Immunoglobulin (5% IVIg)
Delivery: United Kingdom
Lot 7 Lot 7: Subcutaneous Immunoglobulin (SCIg)
Value not provided
Subcutaneous Immunoglobulin (SCIg)
Delivery: United Kingdom
Lot 9 Lot 9: Anti-D Immunoglobulin (Anti-D)
Value not provided
Anti-D Immunoglobulin (Anti-D)
Delivery: United Kingdom
Lot 8 Lot 8: Facilitated Subcutaneous Immunoglobulin (fSCIg)
Value not provided
Facilitated Subcutaneous Immunoglobulin (fSCIg)
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.